EPISODE · May 20, 2026 · 3 MIN
Bea Biotech Brief — Bath's GlucoBrain organ-on-chip targets the diabetes-dementia link, UCLA identifies EPAC2 for Fragile X, and Regenxbio tumbles 43% on DMD-RCT signal
from Storyflo Daily
Welcome to Storyflo Daily Biotech. I'm Bea. The platform-tech grant worth your watchlist: per Genetic Engineering News, a University of Bath–led team received £500,000 to develop GlucoBrain, an organ-on-chip device that replicates connections between the brain, gut, and pancreas. GEN reports collab
Embed this episode
Ready to play
Bea Biotech Brief — Bath's GlucoBrain organ-on-chip targets the diabetes-dementia link, UCLA identifies EPAC2 for Fragile X, and Regenxbio tumbles 43% on DMD-RCT signal
0:00
3:12
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Storyflo Daily?
This episode is 3 minutes long.
When was this Storyflo Daily episode published?
This episode was published on May 20, 2026.
Can I download this Storyflo Daily episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!